The US Supreme Court voiced ambivalence Monday about Microsoft's bid to make it easier for companies to challenge the validity of patents, in a significant case for technology firms and drug makers that has divided the business community.
The US Supreme Court voiced ambivalence Monday about Microsoft's bid to make it easier for companies to challenge the validity of patents, in a significant case for technology firms and drug makers that has divided the business community.